...

首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.

【24h】

Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients.

机译：内科患者预防深静脉血栓形成的成本效益分析。

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis》 |1999年第1期|共4页
作者
Wade WE; Chisholm MA;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;神经病学;
关键词
Cost-Benefit Analysis; Venous Thrombosis; Heparin; Low-Molecular-Weight; 费用效益分析; 静脉血栓形成;

机译：Cost-Benefit Analysis;Venous Thrombosis;Heparin;Low-Molecular-Weight;费用效益分析;静脉血栓形成;

相似文献

外文文献
中文文献
专利

1. Cost-effectiveness analysis of deep vein thrombosis prophylaxis in internal medicine patients. [J] . Wade WE, Chisholm MA Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis . 1999,第1期

机译：内科患者预防深静脉血栓形成的成本效益分析。
2. Low-molecular weight heparin for deep vein thrombosis prophylaxis in hospitalized medical patients: results from a cost-effectiveness analysis. [J] . Shorr AF, Jackson WL, Weiss BM, Blood coagulation & fibrinolysis: an international journal in haemostasis and thrombosis . 2007,第4期

机译：低分子量肝素可预防住院医疗患者的深静脉血栓形成：成本效益分析的结果。
3. Results of an economic model to assess the cost-effectiveness of enoxaparin, a low-molecular-weight heparin, versus warfarin for the prophylaxis of deep vein thrombosis and associated long-term complications in total hip replacement surgery in the Un [J] . Botteman MF, Caprini J, Stephens JM, Clinical therapeutics . 2002,第11期

机译：经济模型评估依诺肝素（一种低分子量肝素）与华法林预防深静脉血栓形成及相关的长期全髋关节置换手术相关长期并发症的成本效益的经济模型结果
4. Design of a non-invasive pulse rate controlled deep vein thrombosis prophylaxis lower limb device [C] . Chandrasekhar K Vinay, Vikas Vazhiyal, Madhav Rao Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2019

机译：无创脉率控制的深静脉血栓形成预防下肢装置的设计
5. Research management of new drug development: A feasibility study of the development of a fixed combination of DHE and heparin for the prophylaxis of postoperative deep vein thrombosis and pulmonary embolism. [D] . DiSerio, Frank Joseph. 1979

机译：新药开发的研究管理：开发DHE和肝素固定组合以预防术后深静脉血栓形成和肺栓塞的可行性研究。
6. A computerized reminder for prophylaxis of deep vein thrombosis in surgical patients. [O] . R. Patterson 1998

机译：预防手术患者深静脉血栓形成的计算机化提醒。
7. PCV17 COST-EFFECTIVENESS ANALYSIS OF DALTEPARIN IN PROLONGED PROPHYLAXIS AGAINST DEEP VEIN THROMBOSIS AFTER HIP ARTHROPLASTY [O] . Segù JL, Soto J 2003

机译：髋关节置换术后深静脉血栓形成加长型脯氨酸酯酶的PCV17成本效益分析

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号